When a steroid “aromatizes,” it means the body converts it into estrogen. This is an enzymatic process where an enzyme called aromatase transforms androgens like testosterone into estrogen compounds. For anyone using anabolic steroids or testosterone replacement therapy, aromatization is one of the most important biological processes to understand, because it directly determines how much estrogen your body produces and the side effects that follow.
How Aromatization Works
Aromatase is an enzyme found throughout your body, particularly in fat tissue, the liver, and the brain. Its job is to convert androgens into estrogens through a three-step chemical process. Testosterone gets converted into estradiol (the most potent form of estrogen), while androstenedione gets converted into estrone (a weaker estrogen). In men, roughly 80% of circulating estradiol is produced this way, through aromatization of testosterone in tissues outside the testes.
The name “aromatize” comes from organic chemistry. During the conversion, the enzyme reshapes the steroid’s A-ring into an aromatic ring, a flat, stable structure. That structural change is what turns an androgen into an estrogen. The enzyme strips away a carbon group and releases it as formic acid, leaving behind the newly aromatized estrogen molecule.
Which Steroids Aromatize and Which Don’t
Not all anabolic steroids aromatize. The ones that do are structurally similar enough to testosterone that the aromatase enzyme can act on them. The ones that don’t have been modified in ways that block the enzyme from binding.
- Aromatizing steroids: Testosterone (all esters), Dianabol (methandrostenolone), Deca-Durabolin (nandrolone, though at a lower rate than testosterone), and Equipoise (boldenone, also at a reduced rate).
- Non-aromatizing steroids: DHT (dihydrotestosterone) and its derivatives, including Winstrol (stanozolol), Anavar (oxandrolone), Masteron (drostanolone), Primobolan (metenolone), and Trenbolone.
The rate of conversion matters as much as whether it happens at all. Testosterone aromatizes readily. Nandrolone aromatizes at roughly 20% the rate of testosterone. Boldenone converts at an even lower rate. These differences mean that a cycle built around testosterone will produce far more estrogen than one built around a compound like nandrolone, even at similar doses.
Why Estrogen Still Matters for Men
Aromatization isn’t a design flaw. Men need estrogen. Estradiol levels are more strongly linked to bone mineral density and bone turnover in men than testosterone levels are. Men with aromatase deficiency or estrogen resistance develop impaired bone growth and accelerated bone loss. Research suggests a threshold exists below which the male skeleton suffers: when estradiol drops below about 20 pg/mL, fracture risk rises and bone maturation slows.
Estrogen also plays a role in cardiovascular health, brain function, and joint lubrication. Crushing estrogen levels to zero with aggressive drug use creates its own set of problems: dry joints, mood disturbances, poor lipid profiles, and weakened bones. The goal is balance, not elimination.
Side Effects of Excess Aromatization
When aromatization runs too high, the excess estrogen produces a predictable set of problems. The most well-known is gynecomastia, the growth of breast tissue in men. This starts as a small, tender lump behind the nipple and can progress to visible breast enlargement if left unchecked. Steroid use is a major driver of gynecomastia because supraphysiological testosterone doses produce proportionally more estrogen than the body normally handles.
Water retention is another hallmark. Elevated estrogen signals the kidneys to hold onto more sodium and water, creating a bloated, puffy appearance that masks muscle definition. This is why bodybuilders on heavily aromatizing compounds often look noticeably “softer” compared to those on non-aromatizing steroids.
Elevated estradiol above about 42.6 pg/mL has been associated with impaired erectile function in men, even when testosterone levels are adequate. Mood changes, including irritability and emotional volatility, are also commonly reported when estrogen swings too high or too low. High blood pressure can follow from the increased water retention.
Body Fat Increases Aromatization
Fat tissue is one of the primary sites where aromatase does its work, and the more fat you carry, the more active the enzyme becomes. Research published in the Journal of Clinical Endocrinology & Metabolism found that aromatase gene expression was significantly higher in fat tissue from men with obesity compared to lean men, with protein levels following the same pattern. Body fat percentage turned out to be the single strongest predictor of aromatase activity.
This creates a feedback loop. More body fat means more aromatase, which converts more testosterone into estrogen, which promotes further fat storage (particularly around the midsection), which increases aromatase activity even more. It also partly explains why men with higher BMIs tend to have lower circulating testosterone. For steroid users, this means that starting a cycle at a higher body fat percentage will produce more estrogenic side effects at the same dose compared to someone who is leaner. Other factors that increase aromatization include age, insulin resistance, and alcohol consumption.
How Estrogen Is Managed
Two classes of drugs are used to manage estrogen during steroid use, and they work in fundamentally different ways.
Aromatase inhibitors (AIs) reduce the amount of estrogen your body produces by blocking the aromatase enzyme itself. Less conversion means lower circulating estradiol. The tradeoff is that AIs can drive estrogen too low if dosed aggressively, leading to the joint pain, fatigue, and mood problems associated with estrogen deficiency.
Selective estrogen receptor modulators (SERMs) take a different approach. Instead of reducing estrogen production, they block estrogen from binding to receptors in specific tissues. A SERM can block estrogen’s effects in breast tissue (preventing gynecomastia) while allowing estrogen to continue its beneficial work in bone and the cardiovascular system. Both AIs and SERMs also increase testosterone production through a secondary mechanism: by reducing estrogen’s feedback signal to the brain, they prompt the pituitary to release more of the hormones that stimulate testosterone production.
In clinical practice, a healthy testosterone-to-estradiol ratio appears to fall between 10 and 30 (calculated as testosterone in ng/dL divided by estradiol in pg/mL). A baseline healthy male might have testosterone around 430 ng/dL and estradiol around 22 pg/mL, yielding a ratio near 19.5. Blood work is the only reliable way to know where your levels stand, since symptoms of high and low estrogen overlap considerably.
Practical Implications for Steroid Users
The degree of aromatization you experience depends on multiple variables: the compound you’re using, the dose, your body fat percentage, your individual genetics (some people express more aromatase naturally), and your age. Two people on the same dose of testosterone can have very different estradiol levels.
Choosing non-aromatizing compounds avoids estrogenic side effects entirely but sacrifices the benefits that estrogen provides. Running high doses of aromatizing compounds without monitoring creates the opposite problem. Most experienced users treat estrogen management as something guided by blood work rather than symptoms alone, because by the time gynecomastia is visible or water retention is obvious, estradiol has typically been elevated for weeks.